Stocktwits on MSN

Zymeworks Shifts To Royalty-Driven Model From Licensed Drugs, Approves $125M Buyback Plan

The proceeds from the development and commercialization of Ziihera, Pasritamig, among others, will be reinvested in the ...
ZAWYA

UAE’s New AI Centre of Excellence unites academia and industry to shape the future of ...

Dubai, United Arab Emirates: A new chapter in the UAE’s technological future begins today with the official opening of the AI ...

NRx Pharmaceuticals outlines rapid clinic expansion and targets 6 or more locations by year ...

Q3 2025 Management View Matthew Duffy, Chief Business Officer & Co-CEO of Hope Therapeutics, opened the call stating, "Since the beginning of the third quarter, NRx has made transformative progress in ...
Kauppalehti

Zymeworks Announces Strategic Initiative to Optimize Value of Licensed Products by Building ...

In order to have the flexibility to opportunistically allocate excess capital to share repurchases, today the Company announced that its Board of Directors has authorized a new share repurchase plan ...
The Manila Times

Worksport ($WKSP) Accelerates U.S. Expansion With Major Missouri Operations Upgrade to ...

Newly Leased Facility Strengthens Operational Capacity, Enhances Engineering Oversight, and Accelerates Commercial Readiness ...
The Manila Times

EHang EH216-S Conducts First Urban Human-Carrying Pilotless eVTOL Flights in the Middle ...

EHang (Nasdaq: EH), the world’s leading Advanced Air Mobility (AAM) technology platform company, announced the successful ...
The Malaysian Reserve

Vanda Pharmaceuticals Reports Positive Results for Tradipitant in Preventing GLP-1 Induced ...

Vanda's Tradipitant Study Success Positions it as Key Adjunct in $50B+ Global GLP-1 Agonist Market WASHINGTON, Nov. 17, 2025 ...